| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |